Impact of Medications on COVID-19 Outcomes in Inflammatory Bowel Disease: Analysis of More Than 6000 Patients From an International Registry
Ryan C. Ungaro, Erica J. Brenner, Manasi Agrawal, Xian Zhang, Michael D. Kappelman, Jean‐Frédéric Colombel, Richard B. Gearry, Gilaad G. Kaplan, Michele Kissous-Hunt, James D. Lewis, Siew C. Ng, Jean‐François Rahier, Walter Reinisch, Flávio Steinwurz
Topics & Concepts
Inflammatory bowel diseaseMedicineCoronavirus disease 2019 (COVID-19)Inflammatory Bowel DiseasesInternal medicine2019-20 coronavirus outbreakDiseaseSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Intensive care medicineGastroenterologyVirologyInfectious disease (medical specialty)OutbreakInflammatory Bowel DiseaseMicroscopic ColitisHealth Systems, Economic Evaluations, Quality of Life